Gemphire is a clinical-stage biopharmaceutical company that is dedicated to finding new ways to treat patients suffering from cardiometabolic disorders. Their main focus is on developing a product candidate called gemcabene, which can be used in combination with standard treatments like statins to provide more effective relief. Their goal is to provide convenient and cost-effective treatment options for a wider range of patients, while also benefiting physicians and payors.
Gemphire Therapeutics Inc's ticker is GEMP
The company's shares trade on the NASDAQ stock exchange
They are based in Livonia, Michigan
There are 11-50 employees working at Gemphire Therapeutics Inc
It is http://www.gemphire.com/
Gemphire Therapeutics Inc is in the Healthcare sector
Gemphire Therapeutics Inc is in the Biotechnology industry
The following five companies are Gemphire Therapeutics Inc's industry peers: